Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver diseaseXinrong Zhang, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al.|Hepatology|2021Cited by 91
Association of genetic variations with NAFLD in lean individualsHuapeng Lin, Vincent Wai‐Sun Wong, Howard H.W. Leung et al.|Liver International|2021Cited by 77
Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver diseaseXinrong Zhang, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al.|Hepatology|2022Cited by 54
Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver diseaseHuapeng Lin, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al.|Hepatology|2022Cited by 50
Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trialXinrong Zhang, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al.|Gut|2023Cited by 47